nondisclosure, agreement, bill
A new bill that would prevent employers from imposing nondisclosure agreements in workplace discrimination cases halted at Gov. Janet Mills desk during the last legislative session in Maine. Pending some amending, Mills is expected to pass the bill during the next session that begins in January. Photo Credit: William Potter/Shutterstock.com

Maine Expected to End Mandatory Nondisclosure Agreements for Workplace Discrimination

A new bill introduced in Maine seeks to stop employers from requiring their employees to sign nondisclosure agreements during workplace harassment and discrimination settlements or upon hiring. The bill, LD 1529, was passed in the Maine House and Senate during the last session but paused at Gov. Janet Mills’ desk because of certain legal concerns. It is set to be amended and is expected to pass during this coming session in January.

Nondisclosure agreements prohibit employees from filing lawsuits against their employers, publicly discussing their situations or publicly speaking about the amount they were awarded.

In June, lawmakers decided to halt the enactment of the bill and recall it from Mills’ desk because of hesitations about the bill’s wording. In April, Peter M. Gore, executive vice president of the Maine State Chamber of Commerce testified about the organization’s concern that the bill would effectively end settlements. If employees do not have to keep quiet about the treatment they’ve faced, employers would not benefit at all from settling with monetary rewards.

In a similar move earlier this year in Baltimore, the Fourth Circuit Court in the state ruled settlements in the cases of police brutality could not have gag orders with non-disparagement clauses. Nondisclosure agreements differ from gag orders because gag orders are issued by courts and not two private parties like in the case of an employee and employer.

Related Story: Baltimore No Longer Able to Offer Police Brutality Settlements with Gag Orders

The LD 1529 bill as written would only allow nondisclosure agreements if the employees themselves want them for privacy reasons. It would allow accusers who opt for a nondisclosure at least three weeks to review agreements before signing and seven days to revoke them if they sign. In June, Mills stated two concerns with the wording of the bill: The wording is too complex and the provisions are not consistent with federal and state law. The U.S. Equal Employment Opportunity Commission and the Maine Human Rights Commission have the right to investigate discrimination cases without victims’ testimonies even if employees have promised not to publicly speak. The bill, which would allow employees to request nondisclosure agreements, could prevent both agencies from doing their jobs.

Of the 3,380 workplace discrimination complaints filed with the Maine Human Rights Commission last year, 471 were of sex discrimination. A majority of those 471 included sexual harassment claims. Coverage of the #MeToo movement drew attention to how nondisclosure agreements aided a culture of silence and perpetuity around sexual misconduct. In the high-profile case of Harvey Weinstein, the former producer was able to use his wealth and power to pay out accusers in exchange for their silence.

Related Story: $44M Settlement with Harvey Weinstein Is Not The Win We Think It Is

Mills, a Democrat, was the Attorney General in Maine and has represented individuals who have claimed harassment in legal cases before. Mills has hinted in statements that once LD 1521’s wording is refined, she is planning on passing it.

Mills “looks forward to working with the sponsors to refine the bill more during the upcoming legislative session,” her press secretary Lindsey Crete told the Bangor Daily News.

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Latest News

boyfriend, loophole, cruz,

Houston Police Chief Blames Republicans Mitch McConnell, Ted Cruz and John Cornyn for ‘Boyfriend Loophole’ Allowing for Officer Shooting Death

Houston Police Chief Art Acevedo addressed the press outside of the medical examiner’s office Monday, suggesting Sgt. Christopher Brewster would not have been killed in the line of duty Saturday if not for the “boyfriend loophole” — a gap in gun legislation that allows domestic violence offenders whose victims are…

Mastercard and Doconomy Extend Collaboration to Deliver a More Sustainable Future

Originally published on Mastercard.com. S&P Global Joins Effort to Power Global Platform Available to All Issuers Further Support Provided by Mastercard Investment in Doconomy Madrid COP25, December 10, 2019 – Doconomy and Mastercard today extended their joint effort to combat climate change. Moving beyond previously announced programs, this new arrangement brings the ability…

As Change Accelerates, Insurers Need Profound Transformation and the Right Talent, Reveals EY Insurance Outlook 2020

Originally posted on EY.com Declining interest rates, changing customer expectations and shifting demographics are defining the future of insurance Insurers must strike the right balance between achieving operational excellence and investing in technology-led innovation As insurance industry growth remains stagnant for another year due to low interest rates, the shifts…

Accenture Named a Leader in Automated Life Insurance Underwriting Systems by Independent Research Firm

Originally posted on Accenture.com Accenture has been named a leader in automated life insurance underwriting systems in a new report from independent research firm Forrester. In the report — “The Forrester Wave™: Automated Life Insurance Underwriting Systems, Q4 2019”[1] — Accenture was named a leader based on the current offering and…

AbbVie and Scripps Research Announce Collaboration to Develop a Broad Range of New Therapeutics

Originally posted on Abbvie.com AbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, today announced a collaboration to develop new therapies for a range of diseases, including in the therapeutic areas of oncology, immunology, neurology, and fibrosis. “Based on our…